Theoretical study of metiamide, a histamine H2 antagonist

Abstract Background Posaconazole is a broad-spectrum antifungal that is not licensed for use in children <13 years of age. Despite this and by necessity, it is used extensively in paediatric hospitals for prophylaxis of invasive fungal disease. Objectives To determine whether initial prophylactic dosing recommendations attain a posaconazole plasma concentration of ≥700 ng/mL in immunocompromised children <13 years of age. Patients and methods We performed a retrospective study of immunocompromised children <13 years of age receiving posaconazole suspension prophylaxis at a starting dose of 5 mg/kg every 8 h for ≥7 days and who had a posaconazole concentration measured after ≥7 days. Posaconazole plasma concentrations and rate of breakthrough infection were recorded. Results A total of 70 patients were included with a median age of 5 years (range 3 months to 12 years). The mean posaconazole plasma concentration was 783.4 ng/mL (IQR 428.3–980 ng/mL) and the percentage of patients with a posaconazole plasma concentration ≥700ng/mL was 47.9%. Patients who were on a proton pump inhibitor, a histamine H2 antagonist or metoclopramide, had mucositis or were enterally fed had a lower posaconazole plasma concentration compared with patients without these co-administered drugs/mucositis/enteral feeding (542.3 versus 1069.8 ng/mL; P<0.001). The breakthrough invasive fungal infection rate was 4.3% (3/70). Conclusions The studied 5 mg/kg posaconazole suspension every 8 h resulted in target concentrations in only 47.9% of patients and further studies looking at newer posaconazole formulations are needed.

Download Full-text

Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.93.13.6802 ◽

1996 ◽

Vol 93 (13) ◽

pp. 6802-6807 ◽

Cited By ~ 167

Author(s):

M. J. Smit ◽

R. Leurs ◽

A. E. Alewijnse ◽

J. Blauw ◽

G. P. Van Nieuw Amerongen ◽

...

Keyword(s):

Inverse Agonism ◽

H2 Antagonist ◽

H2 Receptors ◽

Histamine H2 Antagonist

Download Full-text

Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigen

AJP Gastrointestinal and Liver Physiology ◽

10.1152/ajpgi.1994.267.6.g1087 ◽

1994 ◽

Vol 267 (6) ◽

pp. G1087-G1093 ◽

Cited By ~ 13

Author(s):

T. Frieling ◽

H. J. Cooke ◽

J. D. Wood

Keyword(s):

Presynaptic Inhibition ◽

Neuronal Excitability ◽

Acetylcholine Release ◽

Submucous Plexus ◽

Mucosal Mast Cells ◽

H2 Antagonist ◽

Histamine H2 Antagonist ◽

Antigenic Exposure ◽

Beta Lactoglobulin ◽

Histamine H3

We investigated electrical and synaptic behavior of neurons in the colonic submucous plexus during exposure to beta-lactoglobulin in guinea pigs sensitized by ingestion of milk. Microelectrodes were used to record electrical and synaptic behavior in neurons from milk-sensitized and nonsensitized age-matched animals during exposure to beta-lactoglobulin. Neurons in sensitized animals were hyperexcitable. Application of the histamine H2 antagonist cimetidine reversed the hyperexcitability, suggesting endogenously released histamine as one of the responsible factors. Antigenic exposure suppressed stimulus-evoked nicotinic cholinergic fast excitatory postsynaptic potentials (EPSPs). This was blocked by the selective histamine H3 antagonist burimamide. Suppression of the EPSPs resulted from presynaptic inhibition of acetylcholine release. Increased neuronal excitability and suppression of synaptic transmission was only found in milk-sensitized intestine, not in the intestine from age-matched nonsensitized animals. We concluded that signaling from mucosal mast cells to the enteric nervous system is important in colonic defense against antigenic threats. Histamine is a paracrine messenger in the communication network.

Download Full-text

Renal histamine H1 and H2 receptors: characterization and functional significance

AJP Renal Physiology ◽

10.1152/ajprenal.1978.235.6.f570 ◽

1978 ◽

Vol 235 (6) ◽

pp. F570-F575

Author(s):

R. O. Banks ◽

J. D. Fondacaro ◽

M. M. Schwaiger ◽

E. D. Jacobson

Keyword(s):

Blood Flow ◽

Flow Distribution ◽

Renal Vasculature ◽

H2 Antagonist ◽

H2 Receptors ◽

Chloride Excretion ◽

Intrarenal Blood Flow ◽

Histamine H2 Antagonist ◽

H1 Antagonist ◽

Sustained Increase

Canine experiments were designed to determine if both histamine H1 and H2 receptors are present in the renal circulation. Renal blood flow (RBF) increased steeply over the first minute of intra-arterial histamine infusion, then increased gradually to a plateau in 3– –5 min. Infusion of either histamine + H2 antagonist or of H1 agonist produced the initial rapid increase in RBF, whereas infusion of either histamine + H1 antagonist or of H2 antagonist produced a slower but more sustained increase in RBF. Histamine significantly increased urine flow rate (V), chloride excretion, and glomerular filtration rate (GFR). Infusion of the H2 agonist also increased V and Cl excretion without affecting GFR. By contrast H1 agonist significantly reduced V and Cl excretion and tended to reduce GFR (P less than 0.1 greater than 0.05). Histamine, H1 agonist, and H2 agonist each increased inner cortical more than outer cortical blood flow. These data suggest that 1) H1 and H2 receptors are present in the renal vasculature, 2) changes in intrarenal blood flow distribution are not responsible for histamine-induced diuresis, and 3) H1 receptors are primarily postglomerular while H2 receptors exhibit both pre- and postglomerular distribution.

Download Full-text

Syntheses of 14C and 3H labelled forms of donetidine - A histamine H2-antagonist

Journal of Labelled Compounds and Radiopharmaceuticals ◽

10.1002/jlcr.2580240410 ◽

1987 ◽

Vol 24 (4) ◽

pp. 431-445 ◽

Cited By ~ 2

Author(s):

M A Armitage ◽

M M Cashyap ◽

D Saunders

Keyword(s):

H2 Antagonist ◽

Histamine H2 Antagonist

Download Full-text

Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat

Chirality ◽

10.1002/(sici)1520-636x(1996)8:7<494::aid-chir6>3.0.co;2-b ◽

1996 ◽

Vol 8 (7) ◽

pp. 494-502 ◽

Cited By ~ 12

Author(s):

Akira Fukuhara ◽

Teruko Imai ◽

Masaki Otagiri

Keyword(s):

Gastrointestinal Lesions ◽

H2 Antagonist ◽

Histamine H2 Antagonist ◽

Mutual Prodrug ◽

Stereoselective Disposition

Download Full-text

Increased Thyroxine Clearance in Rats Treated with High Doses of a Histamine H2-Antagonist, SKF 93479

Mechanisms and Models in Toxicology ◽

10.1007/978-3-642-72558-6_45 ◽

1987 ◽

pp. 253-256

Author(s):

C. G. Brown ◽

R. F. Harland ◽

C. K. Atterwill

Keyword(s):

H2 Antagonist ◽

Histamine H2 Antagonist ◽

High Doses

Download Full-text

Regulation of gastroduodenal HCO-3 transport by luminal acid in the frog in vitro

AJP Gastrointestinal and Liver Physiology ◽

10.1152/ajpgi.1984.246.3.g235 ◽

1984 ◽

Vol 246 (3) ◽

pp. G235-G242 ◽

Cited By ~ 8

Author(s):

J. R. Heylings ◽

A. Garner ◽

G. Flemstrom

Keyword(s):

Mucosal Protection ◽

Common Solution ◽

Mucosal Surfaces ◽

H2 Antagonist ◽

Humoral Mechanism ◽

Mammalian Stomach ◽

Histamine H2 Antagonist ◽

Stimulation Of

Luminal acid (10 mM HCl) is a stimulant of surface epithelial HCO-3 transport in mammalian stomach and duodenum in vivo. To determine whether a humoral mechanism is involved in mediation of this response, amphibian fundic, antral, or proximal duodenal mucosae were mounted in parallel in an in vitro chamber with their nutrient (serosal) surfaces facing a common solution. The mucosal surfaces were bathed by separate solutions and the rate of HCO-3 transport by one mucosa titrated (at pH 7.40) during exposure of the parallel tissue to luminal acid. In studies of fundic HCO-3 transport, H+ secretion was inhibited with the histamine H2-antagonist tiotidine (10(-4) M). Fundic luminal acid stimulated HCO-3 transport by a parallel fundus (27 +/- 6%) or antrum (53 +/- 27%) but had no effect on a parallel duodenum. Antral luminal acid had no effect on a parallel antrum, indicating that the gastric stimulant is of fundic origin. Duodenal luminal acid increased HCO-3 transport by both parallel duodenum (21 +/- 5%) and fundus (109 +/- 32%). Stimulation of HCO-3 transport occurred at higher luminal pH in duodenum (approximately 4.0) than in fundus (approximately 2.0). Thus, exposure to luminal acid releases humoral factor(s) capable of stimulating surface epithelial HCO-3 transport by both stomach and duodenum. The actions of these putative stimulants are in part tissue specific, and they may be important in mediation of mucosal protection against luminal acid.

Download Full-text